As per the Directive on the Working Principles and Procedures on Medical Equipment Application of the Social Security Institution published by the Social Security Institution (“Institution”) on 20 April 2016, medical equipment firms continue to make their applications for April 2020 through the Product Monitoring System (“System”) and should submit the required documents during the application period.
However, in order to support companies facing difficulties due to COVID-19 pandemic, the Authority made new regulations regarding the application procedure for April 2020. Within this scope,
- Group C applications will continue to be received electronically through the System without any time extension. However, submission of the documents that should be created after the electronic application and required to be submitted to the Institution during the application period, is not mandatory until Institution’s next announcement.
- Applications for the Allograft Product Group received by being subjected to a preliminary examination in Institution’s relevant units without electronic application will be received during the period without preliminary examination. However, the application file will be submitted directly to the Institution’s document office. If necessary, the applicant firms will be subsequently informed for completion of the application file following the preliminary examination to be conducted before the evaluation process.
- Group A and B applications will also continue to be received and application files will be submitted directly to the Institution’s document office without control procedures made by Institution’s relevant units. If necessary, the applicant firms will be subsequently informed for completion of the application file during the evaluation process.
A copy of the documents that cannot be completed due to the pandemic, especially the documents provided from abroad and other similar documents (originals to be added later), must be included to the application files along with other required documents for both Group A and B and Allograft Product Group applications.
Please see this link for the announcement of the Institution dated 20 April 2020 (only available in Turkish).